We're Here for You!
The IMF is dedicated to improving the quality of life of myeloma patients while working toward prevention and a cure.
Dr. Brian G.M. Durie discusses key takeaways from the annual conference and explains how this new and important information relates to myeloma patients, caregivers, and other members of the myeloma community.
The use of powerful new treatments early in the disease, and four-to-five-year remissions for standard risk patients are just two of the many 2021 trends in patient care Dr. Brian G.M. Durie highlights this week.
The U.S. Food and Drug Administration (FDA) has approved XPOVIO® (selinexor), a first-in-class, oral Selective Inhibitor of Nuclear Export (SINE) medicine, in combination with bortezomib and dexamethasone for the treatment of adult patients with multiple myeloma who have received at least one prior therapy.
In her blog, IMF President, Founder, and CEO Susie Durie compares 2020 and the times of the pandemic to Dickensian times, ultimately finding hope for the future. She writes, “Here I am changing gears to wrap my head around what a ‘pandemic’ really is, how to deal with it, and how to stay safe (and sane) at the same time. What would Dickens have done? I tried to call him, but he didn’t pick up.” Read now for your weekly dose of inspiration.
Need to stay informed about the news that impacts myeloma patients, but don’t have time to read everything out there? Then be sure to follow Dr. Brian Durie’s Week in Review blog. The leading myeloma expert and IMF Chairman of the Board drills down on a wide range of topics – from the latest myeloma research results to the environmental issues that offer insight into prevention. He sifts through the data to deliver the bottom line.
Last year marks the International Myeloma Foundation's (IMF) 30th anniversary, celebrating 30 years of scientific achievement with myeloma patient care at the heart of it all. What started in a garage with a borrowed typewriter is now the largest organization focused specifically on multiple myeloma. The IMF continues to push the needle forward toward a cure for myeloma with cure-focused trials and over 40 active research projects around the world. As IMF President and Founder Susie Durie says, "We are this close to the cure. I can see it on the horizon."
The IMF stands together with the Black community in calling for justice and racial equality. We believe unconditionally, that Black lives matter.
The support of loved ones allows us to continue to fund efforts to search for a cure. Check out how Fundraisers are helping in the fight against myeloma.
